The requirements could cost drugmakers tens of millions of dollars and are likely to leave boosters largely out of reach for hundreds of millions of Americans this fall.
India records a slight increase in COVID-19 cases with 275 active infections. Health authorities are monitoring new variants NB.1.8.1 and LF.7. Most cases are mild and managed at home